Create a living biobank of PDOs from Stage I-III lung cancer patients.
Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
Any clinical stage of lung cancer
Adult patients ≥18 years of age
At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.
The University of Texas Health Science Center at San Antonio
Lead sponsor
National Cancer Institute (NCI)
Collaborator